Chaulagain CP - Search Results

1

Chaulagain CP, Ng J, Wazer D, Saif MW. Chaulagain CP, et al. JOP. 2012 Jul 10;13(4):349-53. doi: 10.6092/1590-8577/935. JOP. 2012. PMID: 22797387 Free article.

2

Adjuvant therapy of pancreatic cancer.

Chaulagain CP, Ng J, Goodman MD, Saif MW. Chaulagain CP, et al. JOP. 2013 Mar 10;14(2):119-22. doi: 10.6092/1590-8577/1461. JOP. 2013. PMID: 23474550 Free article. Review.

3

Is S-1 a potential game changer in adjuvant therapy of pancreatic cancer?

Chaulagain CP, Rothschild J, Saif MW. Chaulagain CP, et al. JOP. 2013 Jul 10;14(4):329-33. doi: 10.6092/1590-8577/1640. JOP. 2013. PMID: 23846920 Free article.

4

One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stress.

Zhou P, Ma X, Iyer L, Chaulagain C, Comenzo RL. Zhou P, et al. Blood. 2014 May 29;123(22):3440-51. doi: 10.1182/blood-2013-10-535187. Epub 2014 Apr 10. Blood. 2014. PMID: 24723680 Free article.

5

Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis.

Kaul E, Shah G, Chaulagain C, Comenzo RL. Kaul E, et al. Bone Marrow Transplant. 2014 Sep;49(9):1233. doi: 10.1038/bmt.2014.117. Epub 2014 Jun 16. Bone Marrow Transplant. 2014. PMID: 24933207 No abstract available.

6

Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Chaulagain CP, Sprague KA, Pilichowska M, Cowan J, Klein AK, Kaul E, Miller KB. Chaulagain CP, et al. Bone Marrow Transplant. 2019 Apr;54(4):560-566. doi: 10.1038/s41409-018-0299-x. Epub 2018 Aug 20. Bone Marrow Transplant. 2019. PMID: 30127467 Free PMC article. Review.

7

New insights and modern treatment of AL amyloidosis.

Chaulagain CP, Comenzo RL. Chaulagain CP, et al. Curr Hematol Malig Rep. 2013 Dec;8(4):291-8. doi: 10.1007/s11899-013-0175-0. Curr Hematol Malig Rep. 2013. PMID: 24026941 Review.

8

Options for Chemotherapy and Scoring Response and Relapse.

Varga C, Chaulagain C. Varga C, et al. Hematol Oncol Clin North Am. 2020 Dec;34(6):1115-1131. doi: 10.1016/j.hoc.2020.07.005. Epub 2020 Sep 28. Hematol Oncol Clin North Am. 2020. PMID: 33099428 Review.

9

How we treat systemic light-chain amyloidosis.

Chaulagain CP, Comenzo RL. Chaulagain CP, et al. Clin Adv Hematol Oncol. 2015 May;13(5):315-24. Clin Adv Hematol Oncol. 2015. PMID: 26352777 Review.

10

siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases.

Ma X, Zhou P, Wong SW, Warner M, Chaulagain C, Comenzo RL. Ma X, et al. Gene Ther. 2016 Oct;23(10):727-733. doi: 10.1038/gt.2016.50. Epub 2016 Jun 20. Gene Ther. 2016. PMID: 27383253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters